Company intelligence / Profile preview

PILL.AR

Córdoba, Córdoba, Argentinapill-ar.com.ar ↗

Ownership: Private
Development stage: Other

Overview

PILL.AR has developed a prototype capable of simultaneously 3D-printing up to two different drugs into a single pill and aims to scale this technology to five drugs per pill. The company’s approach addresses the need for patient-specific medication regimens by automating and personalizing compounding pharmacy processes. Clinical results are not yet available as the company remains in pre-commercial development.

Therapeutic areas: Other
Modalities: Small molecule (custom compounded drugs)VitaminUltra-septic compounds3D printed personalized oral dosage forms
Industry: Therapeutic Medical Devices

Partnerships

Early-stage investment funds (names not specified)

Beyond the preview

Go deeper on PILL.AR.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PILL.AR.

Explore the full profile